News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
HENNER DENNIS
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/11/2023 |
4
| HENNER DENNIS (Director) has filed a Form 4 on Imago BioSciences, Inc.
Txns:
| Unknown transaction of 26,095 shares
@ $36, valued at
$939.4k
Disposed/sold 11,904 options to buy
@ $15.65, valued at
$186.3k
|
|
06/03/2022 |
4
| HENNER DENNIS (Director) has filed a Form 4 on Imago BioSciences, Inc.
Txns:
| Granted 11,904 options to buy
@ $15.65, valued at
$186.3k
|
|
04/07/2020 |
4
| HENNER DENNIS (Director) has filed a Form 4 on Forty Seven, Inc.
Txns:
| Disposed/sold 20,645 options to buy
@ $8.7575, valued at
$180.8k
Disposed/sold 10,322 options to buy
@ $10.81, valued at
$111.6k
|
|
06/14/2019 |
4
| HENNER DENNIS (10% Owner) has filed a Form 4 on Forty Seven, Inc.
Txns:
| Granted 10,322 options to buy
@ $10.81, valued at
$111.6k
|
|
10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Forty Seven, Inc.
Txns:
| Converted 938,489 shares
@ $0 Converted 755,780 shares
@ $0 Converted 1,922,682 shares
@ $0 Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0 Converted 755,780 preferred shares
@ $0 Converted 1,922,682 preferred shares
@ $0 |
|
07/02/2018 |
4
| HENNER DENNIS (10% Owner) has filed a Form 4 on Forty Seven, Inc.
Txns:
| Converted 938,489 shares
@ $0 Converted 755,780 shares
@ $0 Converted 1,922,682 shares
@ $0 Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0 Converted 755,780 preferred shares
@ $0 Converted 1,922,682 preferred shares
@ $0 |
|
10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/10/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP
Txns:
| Sold 103,123 shares
@ $0.19, valued at
$19.6k
Sold 230,507 shares
@ $0.16, valued at
$36.9k
|
|
02/05/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP
Txns:
| Sold 82,583 shares
@ $0.15, valued at
$12.4k
Sold 500,026 shares
@ $0.14, valued at
$70k
Sold 832,881 shares
@ $0.2, valued at
$166.6k
|
|
02/02/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP
Txns:
| Sold 52,826 shares
@ $0.26, valued at
$13.7k
Sold 140,000 shares
@ $0.2, valued at
$28k
Sold 176,306 shares
@ $0.17, valued at
$30k
|
|
01/28/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP
Txns:
| Sold 69,425 shares
@ $0.3, valued at
$20.8k
Sold 209,984 shares
@ $0.27, valued at
$56.7k
Sold 32,521 shares
@ $0.26, valued at
$8.5k
|
|
06/17/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC
Txns:
| Sold 1,529 shares
@ $14.27, valued at
$21.8k
Sold 39,701 shares
@ $14.3, valued at
$567.7k
|
|
06/12/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC
Txns:
| Sold 25,168 shares
@ $14.27, valued at
$359.1k
Sold 6,430 shares
@ $14.25, valued at
$91.6k
|
|
06/10/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC
Txns:
| Sold 2,662 shares
@ $14.25, valued at
$37.9k
Sold 13,000 shares
@ $14.26, valued at
$185.4k
Sold 8,987 shares
@ $14.32, valued at
$128.7k
|
|
06/03/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC
Txns:
| Sold 15,010 shares
@ $14.29, valued at
$214.5k
Sold 11,014 shares
@ $14.25, valued at
$156.9k
Sold 10,450 shares
@ $14.32, valued at
$149.6k
|
|
05/28/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp.
Txns:
| Disposed of 1,554,744 shares
@ $0 |
|
03/24/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC
Txns:
| Sold 27,115 shares
@ $14.53, valued at
$394k
Sold 26,300 shares
@ $14.44, valued at
$379.8k
|
|
03/19/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC
Txns:
| Sold 79,307 shares
@ $14.67, valued at
$1.2M
Sold 25,000 shares
@ $14.68, valued at
$367k
Sold 50,012 shares
@ $14.61, valued at
$730.7k
|
|
01/30/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Disposed of 3,139,447 shares
@ $0 |
|
01/12/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 175,000 shares
@ $31.11, valued at
$5.4M
|
|
01/06/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 13,420 shares
@ $30.67, valued at
$411.6k
Sold 10,200 shares
@ $31.11, valued at
$317.3k
|
|
12/30/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 74,510 shares
@ $30.05, valued at
$2.2M
Sold 6,214 shares
@ $30.03, valued at
$186.6k
|
|
12/24/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 49,441 shares
@ $30.36, valued at
$1.5M
Sold 263 shares
@ $30, valued at
$7.9k
|
|
06/16/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Granted 13,500 options to buy
@ $17.55, valued at
$236.9k
|
|
06/11/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp.
Txns:
| Sold 25,697 shares
@ $46.0156, valued at
$1.2M
Sold 39,362 shares
@ $46.7837, valued at
$1.8M
Sold 79,824 shares
@ $44.6606, valued at
$3.6M
Sold 36,880 shares
@ $45.8956, valued at
$1.7M
Sold 200 shares
@ $46.8, valued at
$9.4k
Sold 29,217 shares
@ $44.5314, valued at
$1.3M
Sold 500 shares
@ $44.32, valued at
$22.2k
|
|
06/10/2014 |
4
| MPM BIOVENTURES III LLC (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns:
| Converted 1,294,134 shares
@ $0 Converted 1,045,351 shares
@ $0 Converted 255,881 shares
@ $0 Converted 399,891 shares
@ $0 Acquired 694,449 shares
@ $0 Converted 269,724 convertible preferred
@ $0 Converted 217,873 convertible preferred
@ $0 Converted 53,331 convertible preferred
@ $0 Converted 91,175 options to buy
@ $0 |
|
12/19/2013 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP
Txns:
| Bought 1,425,063 shares
@ $7, valued at
$10M
Converted 2,342,944 shares
@ $0 Converted 853,416 shares
@ $7, valued at
$6M
Converted 2,342,944 convertible preferred
@ $0 Converted 853,416 convertible notes
@ $7, valued at
$6M
Exercised (in-or-at-the-money) 23,282 warrants
@ $6.4022, valued at
$149.1k
|
|
11/25/2013 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC
Txns:
| Converted 582,456 shares
@ $0 Converted 1,239,308 shares
@ $0 Converted 553,859 shares
@ $0 Converted 203,439 shares
@ $0 Converted 582,456 options to buy
@ $0 Converted 1,239,308 options to buy
@ $0 Converted 553,859 options to buy
@ $0 Converted 203,439 options to buy
@ $0 |
|
10/28/2013 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Converted 2,727,272 shares
@ $0 Converted 420,222 shares
@ $0 Converted 184,812 shares
@ $0.05, valued at
$9.2k
Bought 321,000 shares
@ $10, valued at
$3.2M
Converted 2,727,272 convertible preferred
@ $0 Converted 184,812 options to buy
@ $0.05, valued at
$9.2k
Converted 420,222 convertible notes
@ $0 |
|
10/02/2013 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp.
Txns:
| Converted 2,542,373 shares
@ $0 Converted 186,027 shares
@ $0 Converted 2,542,373 preferred shares
@ $0 Converted 186,027 preferred shares
@ $0 |
|
09/04/2013 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on GLOBUS MEDICAL INC
Txns:
| Disposed of 7,244,201 shares
@ $0 |
|
|
|
|